Category/type | Age (years) | Laterality | Appearance | Typical features | Color score | Picture | Ref |
Endometriosis-related tumors | |||||||
Endometrioma | Median, 34 | Uni/bi | Uni- or multilocular (1–4 locules) | Groundglass content; papillations in 10%, but most often without internal blood flow; premenopausal patient; raised CA 125 (median 44 U/mL) | 1/2/(3) | 171 | |
Benign tumors | |||||||
Sex cord-stromal tumor | |||||||
Fibroma/ fibrothecoma (65%) | Median, 50; 65% postmenopausal | Uni | Regular round, oval or slightly lobulated solid tumors; sometimes multilocular-solid (15–20%) | Fan-shaped shadowing; often raised CA 125 (34%) and/or ascites | (1)/2/3 | 172 | |
Sertoli cell tumor (most benign) | ≤30 (75%) | Uni | Solid; median diameter 90 mm | Hormonally inactive or estrogen-producing (abnormal bleeding) | 3/4 | 173 | |
Leydig cell tumor (almost all benign) | Median, 58 | Uni | Solid; median diameter 24 mm | Endocrine symptoms (75% virilization); testosterone/androstenedione | 3/4 | 173 | |
Germ cell tumor | |||||||
Mature cystic teratoma (dermoid) | Median, 33 | Uni (88%) | Uni- (58%) or multilocular (or uni-/multilocular-solid) | Mixed echogenicity/white ball and stripes/shadowing; CA 19-9 elevated in 30% | 1/2/(3) | † | |
Struma ovarii (entirely or predominantly thyroid tissue); 3% of all ovarian teratomas | Median, 40 | Uni/bi | Multilocular/multilocular-solid; rarely, papillations; fluid anechoic or low-level | ‘Struma pearl’: smooth; roundish solid area; thyrotoxicosis may occur | 1/2/3 | 174 | |
Epithelial | |||||||
Serous cystadenoma | 40–60 | Uni (80–90%) | Uni- or multilocular (2–10 locules) | Anechoic cystic fluid; often papillations without internal blood flow | 1/2 | ‡ | |
Serous cystadenofibroma | 40–60 | Uni (84%) | Multilocular-solid (37%), unilocular-solid (30%), multilocular (19%) or unilocular (13%); median diameter 50–80 mm | 1 (52%), 2 (17%) or 3 (13%) papillations; absent color Doppler signals (80%) and shadows behind papillations (40%) | 1/2 | 175 | |
Mucinous cystadenoma | Median, 50 | Uni (95%) | Multilocular (65%) >10 locules; sometimes unilocular (18%) or multilocular-solid (16%); median diameter 112 mm | Sometimes ‘honeycomb nodule’ | 1/2/(3) | 176 | |
Brenner tumor (99% benign) | 30–70 | Uni | Small solid tumors, 20–80 mm; often extensive calcifications; sometimes multilocular-solid | Small cysts often seen in solid tumors; shadowing; CA 125 raised in 10% | 1/2/(3) | 177 178 | |
Tumor-like lesions | |||||||
Infection | |||||||
Abscess | 16–50 | Uni/bi | Uni-/multilocular | Cogwheel appearance; mixed echogenicity; acute pain; raised CA 125 | 3/4 | 178 | |
Malignant tumors | |||||||
Epithelial | |||||||
Borderline serous | Median, 42; 30% <40 | Uni (73%)/bi (27%) | Unilocular-solid (55%) or multilocular-solid (30%); cystic fluid anechoic (47%) or low-level | >3 irregular papillations (81%) with internal blood flow and anechoic spaces; no shadowing | 2/3 | 179 180 181 182 | |
Borderline mucinous (intestinal type) (30–50%) | Median, 50 | Uni | Multilocular (80%) or unilocular (15%); very large tumor (median diameter 195 mm) | Multiple small loculi, often ‘honeycomb nodule’; no papillations; cystic fluid low-level | 2/3 | 176 180 | |
Borderline mucinous (endocervical type) | 30–40 | Uni | Unilocular-solid; sometimes multilocular-solid; median diameter 37 mm | Papillations (60%); cystic fluid low-level or ground-glass | 2/3 | 176 180 | |
Borderline seromucinous (new category) | Median, 42 | Uni | Contain endometrioid-, indifferent- and squamous-type epithelium | Frequently associated with endometriosis | — | 176 180 | |
Low-grade serous carcinoma | Median, 53 | Bi (60%) | Multilocular-solid (55%) or solid (32%) | Small calcifications in solid tissue; papillations (32%) | 2/3/4 | 181 | |
High-grade serous carcinoma | 55–65 | Bi (50%) | Solid (64%) or multilocular-solid (33%) | Areas of necrosis in solid tissue; rarely, papillations (7%) | 2/3/4 | 181 | |
Mucinous carcinoma (3%) | Median, 53 | Uni (80%) | Multilocular-solid (55%), multilocular or solid | Very large tumor (median diameter 197 mm); cystic fluid low-level | 2/3/(4) | 176 | |
Endometrioid carcinoma (10–15%) | Median, 55 | Uni (79%); co-exist with endometrial carcinoma (20%) | Multilocular-solid (48%) with low-level (53%) or ground-glass (16%) cystic fluid, or solid (34%); median diameter 102 mm | Cockade-like appearance; papillations in 29%; 20% develop from endometriosis | (2)/3/4 | 183 | |
Clear cell carcinoma (5–25%) | Median, 55 | Uni (85%) | Multilocular-solid (41%) or unilocular-solid (35%) with low-level (44%) or ground-glass (22%) cystic fluid, or solid (24%); median diameter 117 mm | Solid nodules; papillations in 38%; 20–30% develop from endometriosis | (2)/3/4 | 184 | |
Carcinosarcoma | Median, 66 (range 33–91) | Bi (50%) | Solid (72.5%); multilocular-solid (24.5%); median diameter 100 mm | Most tumors solid with irregular margins and cystic areas | 3/4 | § | |
Sex cord-stromal tumor | |||||||
Granulosa cell tumor (70%) | 50% premenopausal; 3–10% prepubertal (juvenile type) | Uni | Large multilocular-solid/solid; median diameter 100 mm; heterogeneous solid tissue with areas of necrosis and hemorrhage; echogenicity of fluid mixed or low-level; rarely, papillations | ‘Swiss cheese’ pattern; hyper-estrogenic (abnormal bleeding, thick endometrium); CA 125 normal; estradiol elevated in postmenopause | 3/4 | 185 | |
Sertoli-Leydig-cell tumor | ≤30 (75%) | Uni (100%) | Large multilocular-solid or solid; median diameter 50–150 mm | Endocrine symptoms (one-third virilization); testosterone/androstenedione | 3/4 | 173 | |
Germ cell tumor | |||||||
Dysgerminoma | Median, 20 (range 16–31) | Uni | Highly vascularized, purely solid tumors with heterogeneous internal echogenicity divided into several lobules; smooth and sometimes lobulated contour; well-defined relative to surrounding organs | Internal lobular appearance; raised LDH, sometimes AFP | 3/4 | 186 | |
Yolk sac tumor* | 20–30 | Uni | Large and irregular multilocular-solid/solid (100–200 mm) | Fine-textured slightly hyperechoic solid tissue; raised AFP | 3/4 | 187 188 | |
Immature teratoma | 15–30 | Uni | Large, predominantly solid | Very inhomogeneous solid tissue with hyper-reflective areas; raised AFP | 2/3/4 | ¶ | |
Choriocarcinoma | Median, 36 | Uni | Large, solid (inhomogeneous echogenicity) with small and irregular cystic spaces | Raised hCG | (3)/4 | 189 | |
Embryonal carcinoma | 14–20 | Uni | Large, solid (inhomogeneous echogenicity) with small and irregular cystic spaces | Raised hCG and AFP | (3)/4 | 189 | |
Malignant mixed germ cell tumor | Median, 18 | Uni | Large, solid (inhomogeneous echogenicity) with small and irregular cystic spaces | Raised hCG/LDH/AFP | (3)/4 | 189 | |
Secondary metastatic | |||||||
Breast, stomach, lymphoma or uterus | Median, 56 | Bi (50–75%)/uni | Solid; median diameter 70 mm | ‘Lead-vessel’ sign; CA 125 moderately raised in 75%; CA 15-3 raised (breast) | 3/4 | 190 | |
Colon, rectum, appendix or biliary tract | Median, 56; appendix younger25–50 | Bi (50–75%)/uni | Multilocular/multilocular-solid; median diameter 120 mm; many locules; irregular; papillations | CA 125 moderately raised in 75%; CEA raised (colon, rectum); CA19-9 raised (biliary tract) | (2)/3/(4) | 190 | |
Tumor of Fallopian tube: epithelial | |||||||
Tubal cancer | 55–60 | Uni (90%) | Completely solid or with large solid component(s) and anechoic cystic fluid; average 50 mm | Well-vascularized ovoid or sausage-shaped structure; normal ovarian tissue adjacent in 50% | 3/4 | 191 |
All example images in this table are reproduced from the cited references in Ultrasound in Obstetrics and Gynecology. Color score indicates amount of blood flow within lesion, classified as no detectable flow (color score, 1), minimal flow (color score, 2) moderate flow (color score, 3) or abundant flow (color score, 4); scores in parantheses are less frequent.
*Yolk sac tumor is also named endodermal sinus tumor.
†Heremans et al (personal communication).
‡Virgilio et al (personal communication).
§Ciccarone et al (personal communication).
¶Landolfo et al (personal communication).
AFP, alpha-fetoprotein; Bi, bilateral; hCG, human chorionic gonadoptropin; LDH, lactate dehydrogenase; postmeno, post-menopausal; premeno, pre-menopausal; Ref, reference; Uni, unilateral.